Exchange Announcement • 12 Oct 2026 16:38
Date Of Board Meeting
Exchange Announcement • 29 Sep 2026 20:55
Overseas Regulatory Announcement-Announcement On Unusual Movements In Trading Of Shares
Exchange Announcement • 29 Sep 2026 18:42
Voluntary Announcement Obtainment Of The Drug Supplementary Application Approval Notice For Leuprorelin Acetate Microspheres For Injection 11.25mg (Three-Month Formulation)
Exchange Announcement • 25 Sep 2026 16:33
The 2026 Special Interim Dividend To Reward Shareholders (Updated)
Exchange Announcement • 24 Sep 2026 19:10